Bill Texts: OK HB3834 | 2026 | Regular Session
Bill Title: Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
Sponsorship: Partisan Bill (Republican 3)
Status: (Passed) 2026-05-12 - Approved by Governor 05/12/2026 [HB3834 Detail]
Sponsorship: Partisan Bill (Republican 3)
Status: (Passed) 2026-05-12 - Approved by Governor 05/12/2026 [HB3834 Detail]
Bill Drafts
| Revision | Date | Format | Source | View |
|---|---|---|---|---|
| Enrolled | 2026-05-06 | Link | View | |
| Engrossed | 2026-04-30 | Link | View | |
| Amended | 2026-04-23 | Link | View | |
| Comm Sub | 2026-04-22 | Link | View | |
| Engrossed | 2026-03-12 | Link | View | |
| Amended | 2026-02-20 | Link | View | |
| Introduced | 2026-01-15 | Link | View |
Amendments
| Amendment | Date | Disposition | Format | Source | View |
|---|---|---|---|---|---|
| Senate Committee Committee Amendment | 2026-04-21 | Proposed | Link | View | |
| House Floor 1 Floor Amendment by MAY (UNTIMELY FILED) | 2026-02-25 | Proposed | Link | View |
Supplemental Documents
| Title | Description | Date | Format | Source | View |
|---|---|---|---|---|---|
| Fiscal Note/Analysis | House: Introduced | 2026-02-11 | Link | View | |
| Fiscal Note/Analysis | House: Floor Amendment 1 | 2026-02-25 | Link | View | |
| Fiscal Note/Analysis | Senate: Committee Substitute | 2026-04-27 | Link | View | |
| Fiscal Note/Analysis | House: Senate Amendment to House Bill | 2026-05-04 | Link | View |
